RecruitingNCT05864638

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study

Acute Ischemic Stroke EndoVascular Therapy: a Multicenter REGISTRY Study (OCIN-AIS-EVT REGISTRY)


Sponsor

Changhai Hospital

Enrollment

10,000 participants

Start Date

May 10, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

A Multicenter Registry of Endovascular Treatment for Acute Ischemic Stroke.


Eligibility

Inclusion Criteria3

  • Acute ischemic stroke caused by anterior or posterior circulation vessel occlusion confirmed by computed tomography angiography (CTA) or magnetic resonance angiography (MRA) or digital subtraction angiography (DSA)
  • Undergo intravascular therapy (i.e. access to a cath lab and an arterial puncture)
  • The patient or his/her legal representative agreed to participate in the study and has signed the informed consent.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEEndovascular treatment

Endovascular treatment, such as mechanical thrombectomy with stent, aspiration catheter or stent assisted by intermediate aspiration catheter, as well as combination of mechanical thrombectomy with intra-arterial thrombolysis


Locations(1)

Jianimin Liu

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05864638


Related Trials